Calamos Advisors’s Select Medical SEM Stock Holding History

Calamos Advisors’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-37,120	Closed	-$467K	–	785
2019 Q4	$467K	Buy	+37,120	New	+$400K	﹤0.01%	721

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Calamos Advisors's SEM Position: Q1 2020 in Review

Calamos Advisors sold out of Select Medical (SEM) in Q1 2020, closing a stake of 37,120 shares — an estimated $467K sold.

Calamos Advisors first reported a position in SEM in Q4 2019 and held it in 1 quarter. The position peaked at $467K in Q4 2019. 219 funds tracked by Wall St. Rank hold SEM as of Q1 2020.

Calamos Advisors reported no remaining Select Medical position as of Q1 2020 after selling out during the quarter.
Calamos Advisors sold 37,120 Select Medical shares in Q1 2020, an estimated $467K.
Calamos Advisors first reported a position in Select Medical in Q4 2019 and held it in 1 quarter.
Calamos Advisors's Select Medical position peaked at $467K in Q4 2019.
219 funds tracked by Wall St. Rank held Select Medical as of Q1 2020.

Based on Calamos Advisors's 13F filing for Q1 2020, filed 28 Apr 2020.